MDXH vs. ZEPP, FLGT, BFLY, TALK, LAB, TBRG, SOPH, OM, NYXH, and HCAT
Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include Zepp Health (ZEPP), Fulgent Genetics (FLGT), Butterfly Network (BFLY), Talkspace (TALK), Standard BioTools (LAB), TruBridge (TBRG), SOPHiA GENETICS (SOPH), Outset Medical (OM), Nyxoah (NYXH), and Health Catalyst (HCAT). These companies are all part of the "medical info sys" industry.
MDxHealth vs. Its Competitors
MDxHealth (NASDAQ:MDXH) and Zepp Health (NYSE:ZEPP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.
MDxHealth has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Zepp Health has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.
MDxHealth presently has a consensus price target of $7.00, indicating a potential upside of 69.08%. Zepp Health has a consensus price target of $60.23, indicating a potential upside of 19.79%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts clearly believe MDxHealth is more favorable than Zepp Health.
52.6% of Zepp Health shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
MDxHealth has a net margin of -34.98% compared to Zepp Health's net margin of -38.81%. Zepp Health's return on equity of -24.19% beat MDxHealth's return on equity.
In the previous week, Zepp Health had 4 more articles in the media than MDxHealth. MarketBeat recorded 4 mentions for Zepp Health and 0 mentions for MDxHealth. Zepp Health's average media sentiment score of 0.90 beat MDxHealth's score of 0.00 indicating that Zepp Health is being referred to more favorably in the news media.
MDxHealth has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.
Summary
Zepp Health beats MDxHealth on 8 of the 15 factors compared between the two stocks.
Get MDxHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MDxHealth Competitors List
Related Companies and Tools
This page (NASDAQ:MDXH) was last updated on 10/20/2025 by MarketBeat.com Staff
